导航

硕士生导师介绍

现在的位置: 首页» 教育教学» 研究生教育» 硕士生导师介绍» 专职导师介绍

晏少颖

发布时间:2023-09-14 05:37:28

姓名:晏少颖

职务\职称:主管技师

系别:临床检验诊断学

研究方向:非编码RNA在肝癌发生发展中的分子机制、乙型肝炎

病毒的致癌性研究及乙型肝炎病毒复制调控机制      

工作邮箱:ndyfy06219@ncu.edu.cn

电话:15170050922


个人简介:

       毕业于重庆医科大学(感染性疾病分子生物学教育部重点实验室),现任南昌大学公共卫生学院硕士生导师,江西省研究型医院检验学会青年委员、江西省医学会微生物与免疫分会青年委员。主要研究方向包括非编码RNA在肝癌发生发展中的分子机制、乙型肝炎病毒的致癌性研究、乙型肝炎病毒复制调控机制以及临床检验新方法研究,目前近五年主持有国家级课题1项、省厅级课题5项,已在国内外学术期刊上发表论文10余篇。


论文、专著与专利:

(1) Ai Zhujun#; Li Xinmin#; Chen Rui; Han Daobin; Bai Huijie; Yan Shaoying; Gu Pengcheng; Wu Haiping; Ding Shijia; Chen Junman*; Tang Hua*; Fast three-dimensional DNA walker based on space double-confinement catalytic hairpin assembly for ultrasensitive homogeneous electrochemiluminescence detection of sonic hedgehog, Sensors & Actuators: B. Chemical, 2023, 384: 133631.

(2) Fu Peng#; Gong Binbin#; Li Huiming; Luo Qing; Huang Zikun; Shan Renfeng; Li Junming*; Yan Shaoying*; Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma, Int J Cancer, 2022, 151(10), 1824-1834.

(3) Liu Kanglin#; Yan Shaoying#; Liu Zhengshu#; Wang Dan; Yang Qing; Jiang Xinyun; Chen Liuxian; Tang Hua*;New anti‑tumor strategy based on acid‑triggered self‑destructive and near-infrared laser light responses of nano‑biocatalysts integrating starvation-chemo-photothermal therapies, Cancer Nanotechnology, 2022,13(1):11.

(4) Ling Jiaji#; Jiang Yongmei#; Yan Shaoying#; Dang Hao; Yue Huan; Liu Kanglin; Kuang Linghan; Liu Xingxin; Tang Hua*; A novel pH- and glutathione responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma niche, Cancer Nanotechnology, 2022,13(1):32.

(5) Tang Zhenrong#; Chen Fengjiao#; Wang Dan; Xiong Dongmei; Yan Shaoying; Liu Shengchun; Tang Hua*; Fabrication of avidin-stabilized gold nanoclusters with dual emissions and their application in biosensing, J Nanobiotechnology, 2022, 20(1): 306.

(6) Yan Shaoying#; Tang Zhenrong#; Chen Ke; Liu Yuyang; Yu Gangfeng; Chen Qiuxu; Dang Hao; Chen Fengjiao; Ling Jiaji; Zhu Liying; Huang Ailong*; Tang Hua*; Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression, J Exp Clin Cancer Res, 2018, 37(1): 214.

(7) Yan Shaoying#; Shan Xuefeng#; Liu Yuyang; Yu Gangfeng; Chen Qiuxu; Zeng Tao; Zhu Liying; Dang Hao; Chen Fengjiao; Ling Jiaji; Huang Ailong*; Tang Hua*; LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma, Gene, 2018, 679: 138-149.

(8) Yan Shaoying#; Wang Tianqiong#; Huang Shengwen; Di Yanan; Huang Yunzhu; Liu Xingmei; Luo Zhenyuan; Han Wenping; An Bangquan*; Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes, Acta Diabetol, 2016, 53(5): 693-702.

(9) 晏少颖; 王天琼; 黄盛文; 邸亚楠; 安邦权*; 黄韵祝; 刘兴梅; 罗振元; 韩文平; 糖尿病和糖尿病前期患者血浆微小RNA差异表达谱分析, 广东医学, 2015, (20), 3148-3152.

(10) 晏少颖;龚彬彬,生物标志物在HBV 相关肝癌诊断及预后中的应用, 2022.4.14,中国,ZL202210390496.2 (专利).


主持的科研项目:

(1) 江西省科技厅,青年科学基金项目,20232BAB216067,HBV感染诱导表达的hsa_circ_0001098促进肝癌增殖转移的作用及机制研究,2024-01至2026-12,10万元,在研,主持

(2) 江西省科技厅,面上科学基金项目,20212BAB206036,HBV下调的LINC01979竞争性结合miR-6511b-5p调控TRIM7在肝癌发生发展中的作用,2022-01至2024-12,10万元,在研,主持

(3) 国家自然科学基金委员会,地区项目,82060446,HBV上调的hsa_circ_0007807竞争性结合miR-1249-5p调控TPX2在肝癌发生发展中的作用及机制研究,2021-01至2024-12,34万元,在研,主持

(4) 江西省卫生健康委科技计划项目,202130130,基于高通量测序的HBV相关肝癌circRNA、lncRNA、miRNA和mRNA的筛选及其分子调控网络的初步分析,2021-01至2022-12,自筹,已结题,主持

(5) 江西省科技厅,青年科学基金项目,20202BABL216040,表面增强拉曼散射免疫分析法用于临床乙肝和丙肝病毒表面抗原的多重检测,2020-01至2022-12,6万元,已结题,主持

(6) 江西省教育厅, 科学技术研究项目, GJJ190008, 亲和素稳定的金纳米簇(Av-AuNCs)在多平台的检测应用, 2020-01至2022-12, 5万元, 已结题,主持

(7) 重庆医科大学, 研究生拔尖人才培育计划, BJRC201706, 长链非编码RNA-MIR31HG在肝细胞癌中的功能及其机制研究, 2017-06至2019-06, 5万元, 已结题, 主持